Innophos (NASDAQ:IPHS) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday.
Other research analysts have also recently issued research reports about the stock. TheStreet upgraded shares of Innophos from a “c+” rating to a “b” rating in a report on Wednesday, May 30th. Zacks Investment Research cut shares of Innophos from a “buy” rating to a “hold” rating in a report on Thursday, July 5th.
NASDAQ IPHS opened at $44.69 on Tuesday. The company has a quick ratio of 1.34, a current ratio of 2.75 and a debt-to-equity ratio of 0.99. Innophos has a 52 week low of $38.66 and a 52 week high of $51.34. The company has a market cap of $864.93 million, a price-to-earnings ratio of 18.17 and a beta of 0.73.
Innophos (NASDAQ:IPHS) last issued its earnings results on Monday, July 30th. The specialty chemicals company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.10). Innophos had a net margin of 2.21% and a return on equity of 14.28%. The company had revenue of $206.73 million during the quarter, compared to analyst estimates of $213.40 million. During the same quarter in the previous year, the company posted $0.57 EPS. The company’s quarterly revenue was up 15.4% on a year-over-year basis. research analysts expect that Innophos will post 2.79 EPS for the current fiscal year.
Institutional investors have recently modified their holdings of the company. Itau Unibanco Holding S.A. acquired a new position in shares of Innophos in the 2nd quarter valued at $144,000. Raymond James & Associates acquired a new position in shares of Innophos in the 2nd quarter valued at $209,000. Ifrah Financial Services Inc. acquired a new position in shares of Innophos in the 2nd quarter valued at $210,000. Alps Advisors Inc. acquired a new position in shares of Innophos in the 2nd quarter valued at $213,000. Finally, Piedmont Investment Advisors LLC acquired a new position in shares of Innophos in the 2nd quarter valued at $217,000. Institutional investors and hedge funds own 93.83% of the company’s stock.
Innophos Company Profile
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Recommended Story: How to Use a Moving Average for Trading
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.